The performance of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the expiry in key markets has introduced considerable uncertainty . Investors are now grappling with the effect of rival medications ,